The increasing field of biological therapy relies heavily on recombinant mediator technology, and a thorough understanding of individual profiles is absolutely crucial for optimizing experimental design and therapeutic efficacy. Specifically, examining the attributes of recombinant IL-1A, IL-1B, IL-2, and IL-3 demonstrates important differences … Read More